Status:
WITHDRAWN
Gene-guided Warfarin for Anticoagulation Therapy
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Conditions:
Stroke
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This study will explore the effect of warfarin gene polymorphism on the effectiveness and safety of anticoagulant therapy in patients with acute ischemic stroke, and clarify the correlation between ge...
Eligibility Criteria
Inclusion
- Patients with acute ischemic stroke aged ≥18 years (cardiogenic cerebral embolism patients)
- Clinicians judge that long-term oral anticoagulation with warfarin is required
- No anticoagulation treatment in the past 10 days
- Agree to participate in this project
Exclusion
- Patients who had a tendency to bleed when taking warfarin
- High-risk groups using warfarin anticoagulation
Key Trial Info
Start Date :
December 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04482842
Start Date
December 10 2020
End Date
August 20 2021
Last Update
August 25 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.